FREE U.S. GROUND SHIPPING ON $150+ — U.S. CUSTOMERS ONLY SHOP NOW →
NEW Complimentary MHP Product Research Ebook Included with Qualifying Peptide Orders Complimentary MHP Research Education Ebook Included with Qualifying Orders — A General Educational Guide to Mile High Peptides LLC Products and Research Topics
📦 Holiday Shipping Notice: Due to the three-day holiday weekend, orders placed during this time will ship Tuesday. This helps us avoid extended warehouse and carrier storage where temperatures cannot be reliably monitored. Thank you for your patience and for choosing Mile High Peptides LLC!

MHP IMMUNE-X Research Stack

$84.99

Research Use Disclaimer
Research use only – no guidance

All products are offered for laboratory research and educational purposes only. Mile High Peptides LLC does not provide dosing, reconstitution, administration, stacking, side-effect, or human-use guidance under any circumstances.

Research expectations

Observations in research settings can vary widely based on handling, environment, formulation, and study conditions. No specific outcome, timeline, or result should be assumed or expected from any research material.

View full Research Use Notice

In stock

COA Available Current testing documentation is available for this finished product.
Secure Checkout
Fast Order Processing
U.S.-Based Support

Description

MHP IMMUNE-X Research Stack

The MHP IMMUNE-X Research Stack combines LL-37 and
Thymosin Alpha-1 as two separate research peptides for controlled
laboratory investigation of innate and adaptive immune signaling,
cellular communication, inflammatory-response pathways, and
barrier-associated defense mechanisms.

LL-37 and Thymosin Alpha-1 are investigated through distinct but
complementary areas of immunological research. LL-37 is studied
primarily in models involving innate immune signaling,
barrier-associated biology, and host-response mechanisms, while
Thymosin Alpha-1 is investigated for immune-cell signaling,
immune-response regulation, and interactions between innate and
adaptive immune pathways.

Research Stack Includes

  • LL-37: 5 mg
  • Thymosin Alpha-1: 5 mg
  • Total research material: 10 mg across two separate research components
  • System format: Two separate research materials

Commonly Researched For

  • Innate immune signaling pathways
  • Adaptive immune-response mechanisms
  • Immune-cell communication and signaling
  • Inflammatory-response pathways
  • Barrier-associated defense mechanisms
  • Cellular defense-response signaling
  • Host-response mechanisms in experimental models
  • Interactions between innate and adaptive immune pathways
  • Barrier and immune-signaling relationships
  • Multi-compound immune-signaling research models

About This Research Stack

Immune signaling involves coordinated interactions among innate
immune mechanisms, adaptive immune pathways, immune-cell
communication, inflammatory responses, and physical barrier
systems.

Laboratory models examining these processes allow researchers to
investigate how different components of immune signaling respond,
communicate, and interact under controlled experimental conditions.

LL-37 is a human cathelicidin-derived research
peptide investigated in laboratory models involving innate immune
signaling, cellular communication, inflammatory-response mechanisms,
epithelial biology, and barrier-associated pathways.

Researchers examine LL-37 to better understand host-response
signaling and the relationship between cellular defense mechanisms
and epithelial or barrier-associated systems.

Thymosin Alpha-1 is a research peptide studied in
experimental models involving immune-cell signaling,
immune-response regulation, cellular communication, and interactions
among components of innate and adaptive immune pathways.

Researchers investigate Thymosin Alpha-1 to better understand
signaling relationships among different immune-cell populations
and broader immune-response systems.

Because LL-37 and Thymosin Alpha-1 are studied through different
immune-related mechanisms, MHP IMMUNE-X provides a two-component
research framework for investigating interactions among barrier
biology, innate signaling, immune-cell communication, inflammatory
pathways, and adaptive immune responses.

LL-37 provides a research pathway centered primarily on innate
defense and barrier-associated signaling, while Thymosin Alpha-1
provides a separate pathway involving immune-cell communication
and immune-response regulation.

The compounds are supplied separately rather than combined in one
vial. This allows each research material to be incorporated
independently into appropriately designed experimental protocols
and evaluated as an individual research component.

Product Details

  • Product designation: MHP IMMUNE-X Research Stack
  • Components: LL-37 + Thymosin Alpha-1
  • LL-37 quantity: 5 mg
  • Thymosin Alpha-1 quantity: 5 mg
  • Total research material: 10 mg
  • Format: Lyophilized powder
  • System format: Two separate research components
  • Primary research area: Innate immune, adaptive immune, inflammatory-response, cellular-communication, and barrier-associated signaling
  • Intended use: Laboratory research only
  • Application: Analytical and in-vitro research

Research Use Only

These materials are supplied strictly for laboratory research
and analytical applications. They are not intended for human
consumption or for medical, cosmetic, veterinary, or
therapeutic use.

Research observations may vary depending on methodology,
handling, storage conditions, and experimental design.
Research areas described here do not represent safety,
efficacy, therapeutic benefit, or suitability for human use.

Researcher Responsibility

Purchasers are responsible for ensuring that materials are acquired, handled, stored, and used in accordance with applicable laws, regulations, institutional requirements, and appropriate laboratory practices.

Mile High Peptides LLC supplies compounds strictly for legitimate laboratory research and analytical applications.

Need Quick Answers? Chat With Us on WhatsApp